| Carbohydrate antigen 125 predicts long-term mortality in African American patients with acute decompensated heart failure. | |
| | |
MedLine Citation:
|
PMID: 20078623 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
The goal of this study was to evaluate the relation between serum levels of carbohydrate antigen 125 (CA125) and prognosis in African American (AA) patients with heart failure (HF). Little is known about the usefulness of CA125 in the AA population, which has different pathophysiology and higher prevalence of HF. The authors enrolled 172 consecutive AA patients (mean age, 55.8 years; 61.1% men) admitted with a clinical diagnosis of acute decompensated HF. CA125 was measured within 48+/-12 hours of presentation. Patients were grouped according to CA125 levels into quartiles. The median CA125 level was 16 U/mL. Serum levels of CA125 were elevated (>35 U/mL) in 58 patients (33.7%). Fifty-two patients (30.8%) died over a median follow-up period of 40 months. The CA125 threshold derived from the receiver operating characteristic curves for the prediction of mortality was 35 U/mL. In a multivariate analysis, CA125 levels >35 U/mL were found to be predictive of 40-month all-cause mortality (adjusted hazard ratio, 2.53; confidence interval, 1.40-4.59; P=.002). However, CA125 levels were not associated with 18-month HF rehospitalization. CA125 value is a strong and independent predictor of long-term mortality in AA patients admitted with a diagnosis of acute decompensated HF. Identifying a higher-risk cohort might allow for a more targeted treatment approach. |
| | |
Authors:
|
Ibrahim N Mansour; Sirikarn Napan; M Tarek Alahdab; Thomas D Stamos |
Related Documents
:
|
6127943 - Variable clinical response to long-term angiotensin inhibition in severe heart failure:... 18640343 - Pediatric experience with the ventrassist lvad. 3217463 - Eeg sleep, lithium transport, dexamethasone suppression, and monoamine oxidase activity... |
Publication Detail:
|
Type: Journal Article |
Journal Detail:
|
Title: Congestive heart failure (Greenwich, Conn.) Volume: 16 ISSN: 1751-7133 ISO Abbreviation: Congest Heart Fail Publication Date: 2010 Jan-Feb |
Date Detail:
|
Created Date: 2010-01-18 Completed Date: 2010-04-15 Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 9714174 Medline TA: Congest Heart Fail Country: United States |
Other Details:
|
Languages: eng Pagination: 15-20 Citation Subset: IM |
Copyright Information:
|
2009 Wiley Periodicals, Inc. |
Affiliation:
|
Southern Illinois University School of Medicine, Department of Internal Medicine, Springfield, USA. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Acute Disease African Americans* Biological Markers / blood CA-125 Antigen / blood* Chemiluminescent Measurements Comorbidity Echocardiography Female Heart Failure / blood*, ethnology, mortality*, ultrasonography Humans Male Middle Aged Natriuretic Peptide, Brain / blood Prognosis ROC Curve Sensitivity and Specificity Statistics, Nonparametric Survival Analysis |
| Chemical | |
Reg. No./Substance:
|
0/Biological Markers; 0/CA-125 Antigen; 114471-18-0/Natriuretic Peptide, Brain |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Ablation vs Medical Therapy in the Setting of Symptomatic Atrial Fibrillation and Left Ventricular D...
Next Document: Prevalence of electrocardiographic abnormalities in a systolic heart failure disease management popu...